Fecal ESBL Resurgence During Antibiotic Treatment
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 50
- 主要终点
- fecal carriage of ESBL-E
研究概览
简要总结
Norwegian hospitals are struggling to control spread of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) in health care settings. Strict screening and isolation criteria are enforced in hospital, and patients previously infected by ESBL-E are regarded as possible ESBL-E carriers indefinitely. This observational multi-centre cross-sectional study aims to estimate the duration of fecal ESBL-E carriage and to assess the risk of ESBL-E resurgence during hospital stay for patients previously infected by ESBL-E. Through better knowledge of these risk factors, infection control procedures may be better tailored to rhe individual patient.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with previous infection or colonization with ESBL-E admitted to one of the participating wards. -
排除标准
- •Not able to give informed consent.
结局指标
主要结局
fecal carriage of ESBL-E
时间窗: Baseline
次要结局
- fecal ESBL-E carriage developed during admission(Baseline (admission))
研究者
Silje Bakken Jørgensen
Head of section, infection control officer
University Hospital, Akershus